darifenacin aristo 15mg tableta s prodlouženým uvolňováním
aristo pharma gmbh, berlin array - 14450 darifenacin-hydrobromid - tableta s prodlouženým uvolňováním - 15mg - darifenacin
darifenacin aristo 7,5mg tableta s prodlouženým uvolňováním
aristo pharma gmbh, berlin array - 14450 darifenacin-hydrobromid - tableta s prodlouženým uvolňováním - 7,5mg - darifenacin
emselex
pharmaand gmbh - darifenacin hydrobromidu - urinary incontinence, urge; urinary bladder, overactive - urologicals, drogy pro frekvence močení a inkontinence - symptomatická léčba urgentní inkontinence a/nebo zvýšené frekvence močení a naléhavého jako může dojít u dospělých pacientů se syndromem hyperaktivního močového měchýře.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastická činidla - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
prokanazol 100mg tvrdá tobolka
pro.med.cs praha a.s. array - 9219 itrakonazol - tvrdá tobolka - 100mg - itrakonazol
sporanox 10mg/ml perorální roztok
janssen-cilag s.r.o., praha array - 9219 itrakonazol - perorální roztok - 10mg/ml - itrakonazol
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirotika pro systémové použití - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastická činidla - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastická činidla - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
conisor 100mg tvrdá tobolka
litcon pharma se, praha 8 array - 9219 itrakonazol - tvrdá tobolka - 100mg - itrakonazol